Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-11-13 11:29:21
Oslo, November 13, 2023 - Observe Medical ("the Company" or "Observe Medical")
is pleased to announce the signing of a Letter of Intent (LOI) for a forthcoming
exclusive Nordic distribution agreement for the UnoMeter portfolio with leading
Nordic distributor Vingmed. This LOI represents a significant step towards the
continuation of a strong presence in the Nordic market for UnoMeter, our
innovative urine measurement products.
We are excited about the future opportunities and potential that this strategic
agreement holds for both Vingmed and Observe Medical. Our goal is to ensure that
the final distribution agreement meets the expectations of all parties involved
and creates value for our company, Vingmed and most importantly, our customers -
the hospitals in the Nordic region.
We look forward to sharing additional information and updates with our investors
and stakeholders once the final agreement is formally in place.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About Vingmed
Vingmed provides advanced medical equipment and consumables to Nordic hospitals
and is one of the largest distributors in the Nordic region for intensive care,
surgery, intervention, dialysis, e-health and pharma-management.
For over 50 years, Vingmed has supplied the Nordic healthcare system with
competitive, high-quality products. The Company keeps pace with global market
trends and represent manufacturers with, or potential for, leading positions in
their respective fields and collaborates with companies that prioritize research
and development, relying on strict quality standards in their production.
Further information is available at https://www.vingmed.com/
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.
Further information is available at www.observemedical.com.